Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369082 · ClinicalTrials.gov registry record
Extended Follow-Up After Islet Transplantation in T1D
A clinical trial of Type 1 Diabetes (T1D) and Islet Transplantation, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 75
- Enrollment target
- 8
- Study locations
NCT01369082: Completed study of Type 1 Diabetes (T1D) and Islet Transplantation, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01369082 is a study of Type 1 Diabetes (T1D) and Islet Transplantation that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 75 participants, below the 176-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (57% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01369082, a study of Type 1 Diabetes (T1D) and Islet Transplantation, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.
Primary Outcome
A C-peptide \>/= 0.3 ng/mL at 0, 60, or 90 minutes after a Mixed-Meal Tolerance Test (MMTT) will be considered evidence of insulin production by transplanted islets
Conditions Studied
Interventions
- DRUG Maintenance Immunosuppressive Treatment
Study Locations (8)
Illinois
- Northwestern University - Chicago
- University of Illinois - Chicago
California
- University of California, San Francisco - San Francisco
Florida
- University of Miami - Miami
Georgia
- Emory University - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-07 |
What the finished NCT01369082 record still lists
NCT01369082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 176-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Maintenance Immunosuppressive Treatment is the first listed.
NCT01369082 lists 8 locations in 7 states (Illinois, California, Florida).
Frequently Asked Questions
What is clinical trial NCT01369082 about?
NCT01369082 is a clinical study titled "Extended Follow-Up After Islet Transplantation in T1D". The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications...
What is the current status of trial NCT01369082?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2011-05. Estimated completion is 2017-07.
What conditions does trial NCT01369082 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Islet Transplantation.
What interventions are being tested in trial NCT01369082?
The interventions under investigation include: Maintenance Immunosuppressive Treatment (DRUG).
Who is sponsoring clinical trial NCT01369082?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01369082 being conducted?
This trial has 8 study locations across California, Florida, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01369082's enrollment target sits among peer trials
75 6th of 17 higher than 12 of 17 other Type 1 Diabetes (T1D) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
RECRUITING
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
RECRUITING · NA
-
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
RECRUITING · NA
-
Twiist Postmarket Surveillance Study for Type 1 Diabetes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia